7月 2026
- 首頁
- Pillar Biosciences Inc.
7月 2026Pillar Biosciences Inc.的市場佔有率分析
Explore the top five reasons to go custom with your NGS panel, outlined in this Pillar Biosciences blog post
Pillar Biosciences Inc.(包含公司地區)
查看更多網站流量與參與度資訊- pillarbiosci.com
Pillar Biosciences Inc.的熱門網域總造訪量
了解Pillar Biosciences Inc.市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Pillar Biosciences Inc.的熱門網域平均造訪時長
分析Pillar Biosciences Inc.參與度指標。
過去 3 個月平均造訪時長
子公司細目
Pillar Biosciences Inc.的熱門網域平均頁面瀏覽量
了解Pillar Biosciences Inc.如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Pillar Biosciences Inc.
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞GenomOncology LLC partnered with Pillar Biosciences, Inc. on Feb 1st '25.Similarly, GenomOncology partnered with Pillar Biosciences in February 2025 to pair clinical decision support software with targeted NGS panels for faster, more personalized cancer treatment guidance.
8月 20, 2026閱讀更多
新聞Pillar Biosciences, Inc. partnered with Mitsubishi Chemical Medience Corporation on Aug 20th '26.NATICK, Mass. and TOKYO, Aug. 19, 2026 /PRNewswire/ - Pillar Biosciences, Inc. ("Pillar"), LC-SCRUM-Asia and LSI Medience Corporation ("LSI Medience") today announced a collaboration to support genomic screening of blood-based samples from patients with lung cancer as part of the LC-SCRUM-Asia project in Japan.
8月 19, 2026閱讀更多
新聞CellCarta Group partnered with Pillar Biosciences Incorporated on Apr 2nd '26.CellCarta and Pillar Biosciences announce multi-year global strategic partnership to expand rapid, decentralized tumor profiling for oncology clinical trials.
4月 7, 2026閱讀更多
查看所有Pillar Biosciences Inc.信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
